Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • priya
    Member
    • Apr 2013
    • 57

    Genome size and corrected genome size

    Hi,
    I came across this term "corrected genome size" while reading one paper. Is there any difference between genome size and corrected genome size. If yes, then what needs to be corrected for genome size.
  • amitm
    Member
    • Feb 2011
    • 52

    #2
    hi priya,
    You haven't given any specific detail. Was the term used in context to NGS analysis? Was it referring to a reference genome or a de novo assembled one?

    Comment

    • priya
      Member
      • Apr 2013
      • 57

      #3
      Originally posted by amitm View Post
      hi priya,
      You haven't given any specific detail. Was the term used in context to NGS analysis? Was it referring to a reference genome or a de novo assembled one?
      I came across this term in paper describing normalization of chip-seq reads .
      For your better understanding , I attached screenshoot of lines from the paper .
      Attached Files
      Last edited by priya; 03-09-2015, 03:06 AM.

      Comment

      • amitm
        Member
        • Feb 2011
        • 52

        #4
        hi,
        it seems that corrected genome size is the area of the genome covered by all the ChIP-seq reads in that sample.
        So, if sample A has 20M reads and they cover 2Gb of hg19, then corrected genome size is 2Gb.

        Comment

        • priya
          Member
          • Apr 2013
          • 57

          #5
          Originally posted by amitm View Post
          hi,
          it seems that corrected genome size is the area of the genome covered by all the ChIP-seq reads in that sample.
          So, if sample A has 20M reads and they cover 2Gb of hg19, then corrected genome size is 2Gb.
          Hi amitm,
          Thank you for your reply!

          Can you please clarify me how to calculate the genome coverage from sequencing experiment.
          For sample read coverage, i can easily check the alignment logs (for eg: Bowtie log files), which gives me clearly stat of number of reads mapped per sample.

          Comment

          • amitm
            Member
            • Feb 2011
            • 52

            #6
            hi,
            Once you have done the mapping of reads, use the BAM file obtained to create a BED file.
            Use bedtools -


            Then, the coordinates returned would be overlapping. You need to merge them to create "unique" regions/ coordinate intervals.
            Use -


            Once there, add up the lengths of all intervals and thats the portion of the genome covered, i.e. corrected genome size

            Comment

            • priya
              Member
              • Apr 2013
              • 57

              #7
              Originally posted by amitm View Post
              hi,
              Once you have done the mapping of reads, use the BAM file obtained to create a BED file.
              Use bedtools -


              Then, the coordinates returned would be overlapping. You need to merge them to create "unique" regions/ coordinate intervals.
              Use -


              Once there, add up the lengths of all intervals and thats the portion of the genome covered, i.e. corrected genome size
              Hi amitm,
              Thanks alot for your clear explaination. I will try it out

              Comment

              • AlexReynolds
                Member
                • Feb 2013
                • 45

                #8
                You can use BEDOPS bam2bed to convert from BAM to BED, pipe to bedops to merge overlapping elements, and pipe to bedmap to generate a list of lengths per merged element to sum with awk:

                $ bam2bed < foo.bam | bedops --merge - | bedmap --echo-overlap-size - | awk '{s += $1;} END {print s;}' > answer.txt

                In this case, bedmap is mapping merged elements against themselves. Merged elements coming out of bedops are guaranteed to be disjoint, so --echo-overlap-size is guaranteed to report the unique length of each merged element.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                31 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-23-2026, 11:41 AM
                0 responses
                23 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                214 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                79 views
                0 reactions
                Last Post SEQadmin2  
                Working...